Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes.
about
Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets.Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.Cholera and severe toxigenic diarrhoeas.Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsOral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit.A launch vector for the production of vaccine antigens in plants.Recent developments in mucosal vaccines against prion diseases.Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes.Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.Future directions for the development of Chlamydomonas-based vaccines.Recent progress concerning CpG DNA and its use as a vaccine adjuvant.The Escherichia coli heat labile toxin binds to Golgi membranes and alters Golgi and cell morphologies using ADP-ribosylation factor-dependent processes.Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.N-terminus of mature heat-labile enterotoxin chain B is critical for its extracellular secretion in Vibrio cholerae
P2860
Q33611559-E8725D68-76ED-42D1-ADCB-2A626597A6A1Q34003291-33DC0FC5-95D1-4365-B9C6-00978E773670Q34377835-53774BB4-3B38-4C5F-88D3-52D3326A95C9Q34639828-1DEAF4BD-8641-40E1-A414-0372DD0CDB76Q35543988-ED791531-3A3E-443F-B55B-280321B4A784Q35757940-416F240B-DE7C-47FC-87BD-C23744257EE3Q36252789-7D2BD888-7D03-41D7-B14F-EDE4A84DF357Q36728797-A1A2244B-5E22-402B-BF6F-CFFD60AFE17BQ37859086-0C9DBB8A-096C-4114-B0B1-4C404AA68282Q37867011-012AF073-D0C6-47A7-B36B-8CD5037620AAQ38140036-ED816170-E874-4279-A1F9-0131E76C0C35Q38168903-F2ACBED3-E67B-4AB8-B8FA-78A2831149FCQ42503729-E581E303-1497-4F22-9DE8-34D04A5EEB1BQ47672789-B30EAEA7-E861-40E4-B9BA-55D120A68BC6Q47837375-D113A41D-3710-461F-B054-AC7148C257F3Q57956675-DD31A3AF-F217-43BA-AC8B-7D15522627A3
P2860
Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Current progress in the develo ...... ologous antigens and epitopes.
@en
type
label
Current progress in the develo ...... ologous antigens and epitopes.
@en
prefLabel
Current progress in the develo ...... ologous antigens and epitopes.
@en
P2093
P1433
P1476
Current progress in the develo ...... ologous antigens and epitopes.
@en
P2093
P304
P356
10.1016/0264-410X(93)90023-Q
P407
P577
1993-01-01T00:00:00Z